nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—Somnambulism—Varenicline—nicotine dependence	0.0328	0.0431	CcSEcCtD
Sertraline—Peripheral ischaemia—Varenicline—nicotine dependence	0.018	0.0237	CcSEcCtD
Sertraline—Varicose vein—Varenicline—nicotine dependence	0.0176	0.0232	CcSEcCtD
Sertraline—Aphthous stomatitis—Varenicline—nicotine dependence	0.014	0.0184	CcSEcCtD
Sertraline—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0127	0.0167	CcSEcCtD
Sertraline—Suicide—Varenicline—nicotine dependence	0.0127	0.0167	CcSEcCtD
Sertraline—Hostility—Varenicline—nicotine dependence	0.0119	0.0156	CcSEcCtD
Sertraline—Sexual dysfunction—Varenicline—nicotine dependence	0.0117	0.0154	CcSEcCtD
Sertraline—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0117	0.0545	CbGpPWpGaD
Sertraline—Suicide attempt—Varenicline—nicotine dependence	0.0116	0.0152	CcSEcCtD
Sertraline—Completed suicide—Varenicline—nicotine dependence	0.0112	0.0147	CcSEcCtD
Sertraline—Maprotiline—DRD2—nicotine dependence	0.0112	1	CrCbGaD
Sertraline—Libido increased—Varenicline—nicotine dependence	0.0108	0.0142	CcSEcCtD
Sertraline—Vaginal discharge—Varenicline—nicotine dependence	0.0108	0.0142	CcSEcCtD
Sertraline—Menstrual disorder—Varenicline—nicotine dependence	0.00965	0.0127	CcSEcCtD
Sertraline—Paranoia—Varenicline—nicotine dependence	0.00965	0.0127	CcSEcCtD
Sertraline—Suicidal ideation—Varenicline—nicotine dependence	0.00938	0.0123	CcSEcCtD
Sertraline—Delusion—Varenicline—nicotine dependence	0.00929	0.0122	CcSEcCtD
Sertraline—Nystagmus—Varenicline—nicotine dependence	0.0092	0.0121	CcSEcCtD
Sertraline—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0091	0.0425	CbGpPWpGaD
Sertraline—Mania—Varenicline—nicotine dependence	0.00904	0.0119	CcSEcCtD
Sertraline—Menorrhagia—Varenicline—nicotine dependence	0.00888	0.0117	CcSEcCtD
Sertraline—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00881	0.0412	CbGpPWpGaD
Sertraline—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00873	0.0115	CcSEcCtD
Sertraline—Scotoma—Varenicline—nicotine dependence	0.00866	0.0114	CcSEcCtD
Sertraline—Mydriasis—Varenicline—nicotine dependence	0.00824	0.0108	CcSEcCtD
Sertraline—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00811	0.0379	CbGpPWpGaD
Sertraline—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00804	0.0375	CbGpPWpGaD
Sertraline—Dysphonia—Varenicline—nicotine dependence	0.00799	0.0105	CcSEcCtD
Sertraline—Endocrine disorder—Varenicline—nicotine dependence	0.00793	0.0104	CcSEcCtD
Sertraline—Disturbance in attention—Varenicline—nicotine dependence	0.00759	0.00998	CcSEcCtD
Sertraline—Aggression—Varenicline—nicotine dependence	0.00748	0.00984	CcSEcCtD
Sertraline—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00723	0.0338	CbGpPWpGaD
Sertraline—Thinking abnormal—Varenicline—nicotine dependence	0.00718	0.00944	CcSEcCtD
Sertraline—Nocturia—Varenicline—nicotine dependence	0.00709	0.00932	CcSEcCtD
Sertraline—Coordination abnormal—Varenicline—nicotine dependence	0.0067	0.0088	CcSEcCtD
Sertraline—Abnormal dreams—Varenicline—nicotine dependence	0.0065	0.00854	CcSEcCtD
Sertraline—Eructation—Varenicline—nicotine dependence	0.00646	0.00849	CcSEcCtD
Sertraline—Salivary hypersecretion—Varenicline—nicotine dependence	0.00639	0.00839	CcSEcCtD
Sertraline—Nightmare—Varenicline—nicotine dependence	0.00635	0.00835	CcSEcCtD
Sertraline—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00632	0.0295	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00619	0.0289	CbGpPWpGaD
Sertraline—Photophobia—Varenicline—nicotine dependence	0.00617	0.00812	CcSEcCtD
Sertraline—Oesophagitis—Varenicline—nicotine dependence	0.00601	0.0079	CcSEcCtD
Sertraline—Mouth ulceration—Varenicline—nicotine dependence	0.00594	0.00781	CcSEcCtD
Sertraline—Urine output increased—Varenicline—nicotine dependence	0.00594	0.00781	CcSEcCtD
Sertraline—Hypertonia—Varenicline—nicotine dependence	0.00576	0.00758	CcSEcCtD
Sertraline—Mental disability—Varenicline—nicotine dependence	0.00571	0.0075	CcSEcCtD
Sertraline—Euphoric mood—Varenicline—nicotine dependence	0.00565	0.00743	CcSEcCtD
Sertraline—Lymphadenopathy—Varenicline—nicotine dependence	0.00559	0.00735	CcSEcCtD
Sertraline—Diabetes mellitus—Varenicline—nicotine dependence	0.00549	0.00721	CcSEcCtD
Sertraline—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00546	0.0255	CbGpPWpGaD
Sertraline—Polyuria—Varenicline—nicotine dependence	0.00544	0.00715	CcSEcCtD
Sertraline—Eczema—Varenicline—nicotine dependence	0.00531	0.00698	CcSEcCtD
Sertraline—Eye pain—Varenicline—nicotine dependence	0.00529	0.00695	CcSEcCtD
Sertraline—Renal failure acute—Varenicline—nicotine dependence	0.00517	0.0068	CcSEcCtD
Sertraline—Libido decreased—Varenicline—nicotine dependence	0.00515	0.00677	CcSEcCtD
Sertraline—Hot flush—Varenicline—nicotine dependence	0.0051	0.00671	CcSEcCtD
Sertraline—Amnesia—Varenicline—nicotine dependence	0.00508	0.00668	CcSEcCtD
Sertraline—Increased appetite—Varenicline—nicotine dependence	0.00508	0.00668	CcSEcCtD
Sertraline—Menopausal symptoms—Varenicline—nicotine dependence	0.00506	0.00665	CcSEcCtD
Sertraline—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00502	0.0235	CbGpPWpGaD
Sertraline—Thirst—Varenicline—nicotine dependence	0.00501	0.00659	CcSEcCtD
Sertraline—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00498	0.0233	CbGpPWpGaD
Sertraline—Hypoglycaemia—Varenicline—nicotine dependence	0.00489	0.00643	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00477	0.00627	CcSEcCtD
Sertraline—Osteoarthritis—Varenicline—nicotine dependence	0.00477	0.00627	CcSEcCtD
Sertraline—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00473	0.00622	CcSEcCtD
Sertraline—Affect lability—Varenicline—nicotine dependence	0.0047	0.00618	CcSEcCtD
Sertraline—Migraine—Varenicline—nicotine dependence	0.0047	0.00618	CcSEcCtD
Sertraline—Psychotic disorder—Varenicline—nicotine dependence	0.00466	0.00613	CcSEcCtD
Sertraline—Urinary retention—Varenicline—nicotine dependence	0.00454	0.00597	CcSEcCtD
Sertraline—Mood swings—Varenicline—nicotine dependence	0.00452	0.00594	CcSEcCtD
Sertraline—Dry skin—Varenicline—nicotine dependence	0.00437	0.00575	CcSEcCtD
Sertraline—Breast disorder—Varenicline—nicotine dependence	0.00431	0.00567	CcSEcCtD
Sertraline—Cramp muscle—Varenicline—nicotine dependence	0.0043	0.00565	CcSEcCtD
Sertraline—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00426	0.0199	CbGpPWpGaD
Sertraline—Gastritis—Varenicline—nicotine dependence	0.00422	0.00555	CcSEcCtD
Sertraline—Abdominal distension—Varenicline—nicotine dependence	0.00415	0.00546	CcSEcCtD
Sertraline—Dysphagia—Varenicline—nicotine dependence	0.00413	0.00542	CcSEcCtD
Sertraline—Bronchitis—Varenicline—nicotine dependence	0.00397	0.00522	CcSEcCtD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00389	0.0181	CbGpPWpGaD
Sertraline—Pollakiuria—Varenicline—nicotine dependence	0.00381	0.00501	CcSEcCtD
Sertraline—Erectile dysfunction—Varenicline—nicotine dependence	0.0038	0.00499	CcSEcCtD
Sertraline—Photosensitivity reaction—Varenicline—nicotine dependence	0.00377	0.00495	CcSEcCtD
Sertraline—Weight increased—Varenicline—nicotine dependence	0.00375	0.00494	CcSEcCtD
Sertraline—Hyperglycaemia—Varenicline—nicotine dependence	0.00372	0.00489	CcSEcCtD
Sertraline—Depression—Varenicline—nicotine dependence	0.00367	0.00482	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00365	0.00479	CcSEcCtD
Sertraline—Acute coronary syndrome—Varenicline—nicotine dependence	0.00363	0.00477	CcSEcCtD
Sertraline—Myocardial infarction—Varenicline—nicotine dependence	0.00361	0.00474	CcSEcCtD
Sertraline—Stomatitis—Varenicline—nicotine dependence	0.00359	0.00471	CcSEcCtD
Sertraline—Conjunctivitis—Varenicline—nicotine dependence	0.00358	0.0047	CcSEcCtD
Sertraline—Hepatobiliary disease—Varenicline—nicotine dependence	0.00348	0.00457	CcSEcCtD
Sertraline—Epistaxis—Varenicline—nicotine dependence	0.00347	0.00456	CcSEcCtD
Sertraline—Sinusitis—Varenicline—nicotine dependence	0.00345	0.00454	CcSEcCtD
Sertraline—Bradycardia—Varenicline—nicotine dependence	0.00336	0.00442	CcSEcCtD
Sertraline—MAOB—Biological oxidations—CYP2A7—nicotine dependence	0.00329	0.0154	CbGpPWpGaD
Sertraline—Hypoaesthesia—Varenicline—nicotine dependence	0.00329	0.00432	CcSEcCtD
Sertraline—Hallucination—Varenicline—nicotine dependence	0.00329	0.00432	CcSEcCtD
Sertraline—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00329	0.0153	CbGpPWpGaD
Sertraline—Urinary tract disorder—Varenicline—nicotine dependence	0.00326	0.00429	CcSEcCtD
Sertraline—Oedema peripheral—Varenicline—nicotine dependence	0.00325	0.00428	CcSEcCtD
Sertraline—Connective tissue disorder—Varenicline—nicotine dependence	0.00324	0.00427	CcSEcCtD
Sertraline—Urethral disorder—Varenicline—nicotine dependence	0.00324	0.00425	CcSEcCtD
Sertraline—Visual impairment—Varenicline—nicotine dependence	0.00318	0.00418	CcSEcCtD
Sertraline—Erythema multiforme—Varenicline—nicotine dependence	0.00312	0.0041	CcSEcCtD
Sertraline—Eye disorder—Varenicline—nicotine dependence	0.00309	0.00406	CcSEcCtD
Sertraline—Tinnitus—Varenicline—nicotine dependence	0.00308	0.00405	CcSEcCtD
Sertraline—Cardiac disorder—Varenicline—nicotine dependence	0.00306	0.00403	CcSEcCtD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.003	0.014	CbGpPWpGaD
Sertraline—Angiopathy—Varenicline—nicotine dependence	0.003	0.00394	CcSEcCtD
Sertraline—Immune system disorder—Varenicline—nicotine dependence	0.00298	0.00392	CcSEcCtD
Sertraline—Mediastinal disorder—Varenicline—nicotine dependence	0.00298	0.00391	CcSEcCtD
Sertraline—Chills—Varenicline—nicotine dependence	0.00296	0.00389	CcSEcCtD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00296	0.0138	CbGpPWpGaD
Sertraline—Arrhythmia—Varenicline—nicotine dependence	0.00295	0.00388	CcSEcCtD
Sertraline—Mental disorder—Varenicline—nicotine dependence	0.00289	0.0038	CcSEcCtD
Sertraline—Malnutrition—Varenicline—nicotine dependence	0.00287	0.00378	CcSEcCtD
Sertraline—Erythema—Varenicline—nicotine dependence	0.00287	0.00378	CcSEcCtD
Sertraline—Flatulence—Varenicline—nicotine dependence	0.00283	0.00372	CcSEcCtD
Sertraline—Dysgeusia—Varenicline—nicotine dependence	0.00281	0.0037	CcSEcCtD
Sertraline—Back pain—Varenicline—nicotine dependence	0.00278	0.00365	CcSEcCtD
Sertraline—Muscle spasms—Varenicline—nicotine dependence	0.00276	0.00363	CcSEcCtD
Sertraline—Tremor—Varenicline—nicotine dependence	0.00269	0.00354	CcSEcCtD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00267	0.0125	CbGpPWpGaD
Sertraline—Ill-defined disorder—Varenicline—nicotine dependence	0.00267	0.00351	CcSEcCtD
Sertraline—Anaemia—Varenicline—nicotine dependence	0.00266	0.00349	CcSEcCtD
Sertraline—Agitation—Varenicline—nicotine dependence	0.00264	0.00347	CcSEcCtD
Sertraline—Angioedema—Varenicline—nicotine dependence	0.00263	0.00345	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00261	0.0122	CbGpPWpGaD
Sertraline—Malaise—Varenicline—nicotine dependence	0.00259	0.00341	CcSEcCtD
Sertraline—Vertigo—Varenicline—nicotine dependence	0.00258	0.00339	CcSEcCtD
Sertraline—Syncope—Varenicline—nicotine dependence	0.00258	0.00339	CcSEcCtD
Sertraline—Palpitations—Varenicline—nicotine dependence	0.00254	0.00334	CcSEcCtD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00253	0.0118	CbGpPWpGaD
Sertraline—Loss of consciousness—Varenicline—nicotine dependence	0.00253	0.00332	CcSEcCtD
Sertraline—Cough—Varenicline—nicotine dependence	0.00251	0.0033	CcSEcCtD
Sertraline—Convulsion—Varenicline—nicotine dependence	0.00249	0.00327	CcSEcCtD
Sertraline—Hypertension—Varenicline—nicotine dependence	0.00248	0.00326	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00248	0.0116	CbGpPWpGaD
Sertraline—Arthralgia—Varenicline—nicotine dependence	0.00245	0.00322	CcSEcCtD
Sertraline—Myalgia—Varenicline—nicotine dependence	0.00245	0.00322	CcSEcCtD
Sertraline—Chest pain—Varenicline—nicotine dependence	0.00245	0.00322	CcSEcCtD
Sertraline—Anxiety—Varenicline—nicotine dependence	0.00244	0.00321	CcSEcCtD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00243	0.0114	CbGpPWpGaD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00243	0.00319	CcSEcCtD
Sertraline—Discomfort—Varenicline—nicotine dependence	0.00242	0.00318	CcSEcCtD
Sertraline—Dry mouth—Varenicline—nicotine dependence	0.00239	0.00315	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00235	0.011	CbGpPWpGaD
Sertraline—Oedema—Varenicline—nicotine dependence	0.00235	0.00308	CcSEcCtD
Sertraline—Shock—Varenicline—nicotine dependence	0.00231	0.00303	CcSEcCtD
Sertraline—Nervous system disorder—Varenicline—nicotine dependence	0.0023	0.00302	CcSEcCtD
Sertraline—Thrombocytopenia—Varenicline—nicotine dependence	0.0023	0.00302	CcSEcCtD
Sertraline—Tachycardia—Varenicline—nicotine dependence	0.00229	0.00301	CcSEcCtD
Sertraline—Skin disorder—Varenicline—nicotine dependence	0.00228	0.003	CcSEcCtD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00227	0.0106	CbGpPWpGaD
Sertraline—Hyperhidrosis—Varenicline—nicotine dependence	0.00227	0.00298	CcSEcCtD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00224	0.0105	CbGpPWpGaD
Sertraline—Anorexia—Varenicline—nicotine dependence	0.00224	0.00294	CcSEcCtD
Sertraline—Hypotension—Varenicline—nicotine dependence	0.00219	0.00288	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00214	0.00999	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00214	0.00281	CcSEcCtD
Sertraline—Insomnia—Varenicline—nicotine dependence	0.00212	0.00279	CcSEcCtD
Sertraline—Dyspnoea—Varenicline—nicotine dependence	0.00209	0.00275	CcSEcCtD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00209	0.00975	CbGpPWpGaD
Sertraline—Somnolence—Varenicline—nicotine dependence	0.00209	0.00274	CcSEcCtD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00207	0.00966	CbGpPWpGaD
Sertraline—Dyspepsia—Varenicline—nicotine dependence	0.00206	0.00271	CcSEcCtD
Sertraline—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.00206	0.00964	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00206	0.00962	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00204	0.00955	CbGpPWpGaD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00204	0.00954	CbGpPWpGaD
Sertraline—Decreased appetite—Varenicline—nicotine dependence	0.00204	0.00268	CcSEcCtD
Sertraline—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00203	0.00266	CcSEcCtD
Sertraline—Fatigue—Varenicline—nicotine dependence	0.00202	0.00266	CcSEcCtD
Sertraline—Pain—Varenicline—nicotine dependence	0.00201	0.00264	CcSEcCtD
Sertraline—Constipation—Varenicline—nicotine dependence	0.00201	0.00264	CcSEcCtD
Sertraline—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.00194	0.00906	CbGpPWpGaD
Sertraline—Feeling abnormal—Varenicline—nicotine dependence	0.00193	0.00254	CcSEcCtD
Sertraline—Gastrointestinal pain—Varenicline—nicotine dependence	0.00192	0.00252	CcSEcCtD
Sertraline—SLC6A3—Neuronal System—CHRNB3—nicotine dependence	0.0019	0.00888	CbGpPWpGaD
Sertraline—Urticaria—Varenicline—nicotine dependence	0.00186	0.00245	CcSEcCtD
Sertraline—Abdominal pain—Varenicline—nicotine dependence	0.00185	0.00244	CcSEcCtD
Sertraline—Body temperature increased—Varenicline—nicotine dependence	0.00185	0.00244	CcSEcCtD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00184	0.00859	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00183	0.00855	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHRNA6—nicotine dependence	0.0018	0.00842	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00177	0.00826	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00175	0.00819	CbGpPWpGaD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00174	0.00815	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00174	0.00814	CbGpPWpGaD
Sertraline—Hypersensitivity—Varenicline—nicotine dependence	0.00173	0.00227	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0017	0.00794	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00169	0.0079	CbGpPWpGaD
Sertraline—Asthenia—Varenicline—nicotine dependence	0.00168	0.00221	CcSEcCtD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00168	0.00783	CbGpPWpGaD
Sertraline—Pruritus—Varenicline—nicotine dependence	0.00166	0.00218	CcSEcCtD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00163	0.00762	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00163	0.00761	CbGpPWpGaD
Sertraline—Diarrhoea—Varenicline—nicotine dependence	0.0016	0.00211	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00158	0.00739	CbGpPWpGaD
Sertraline—Dizziness—Varenicline—nicotine dependence	0.00155	0.00204	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00152	0.00708	CbGpPWpGaD
Sertraline—Vomiting—Varenicline—nicotine dependence	0.00149	0.00196	CcSEcCtD
Sertraline—Rash—Varenicline—nicotine dependence	0.00148	0.00194	CcSEcCtD
Sertraline—Dermatitis—Varenicline—nicotine dependence	0.00148	0.00194	CcSEcCtD
Sertraline—Headache—Varenicline—nicotine dependence	0.00147	0.00193	CcSEcCtD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00143	0.00669	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00143	0.00667	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00142	0.00664	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—GABRA4—nicotine dependence	0.0014	0.00655	CbGpPWpGaD
Sertraline—Nausea—Varenicline—nicotine dependence	0.00139	0.00183	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00137	0.00641	CbGpPWpGaD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00136	0.00637	CbGpPWpGaD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00135	0.00629	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.00134	0.00628	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00133	0.00621	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—GABRA4—nicotine dependence	0.0013	0.00609	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0013	0.00606	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00129	0.00604	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00127	0.00596	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.00125	0.00584	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHRNB4—nicotine dependence	0.00125	0.00583	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00124	0.00577	CbGpPWpGaD
Sertraline—MAOB—cardiovascular system—nicotine dependence	0.00122	0.0865	CbGeAlD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00117	0.00547	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHRNA5—nicotine dependence	0.00116	0.00542	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00111	0.00517	CbGpPWpGaD
Sertraline—SLC6A3—midbrain—nicotine dependence	0.00109	0.0776	CbGeAlD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00109	0.00508	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00106	0.00496	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.00105	0.00491	CbGpPWpGaD
Sertraline—MAOA—cardiovascular system—nicotine dependence	0.00104	0.0738	CbGeAlD
Sertraline—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00104	0.00484	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.00102	0.00476	CbGpPWpGaD
Sertraline—SLC6A4—midbrain—nicotine dependence	0.001	0.0711	CbGeAlD
Sertraline—SIGMAR1—midbrain—nicotine dependence	0.000994	0.0706	CbGeAlD
Sertraline—SLC6A3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000987	0.00461	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000977	0.00456	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000963	0.0045	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000953	0.00445	CbGpPWpGaD
Sertraline—MAOB—midbrain—nicotine dependence	0.000952	0.0676	CbGeAlD
Sertraline—SLC6A3—Neuronal System—CHRNA3—nicotine dependence	0.000946	0.00442	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000945	0.00441	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000898	0.0042	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.000897	0.00419	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000891	0.00416	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000886	0.00414	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000878	0.0041	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHRNB2—nicotine dependence	0.000833	0.00389	CbGpPWpGaD
Sertraline—CYP2B6—cardiovascular system—nicotine dependence	0.000831	0.059	CbGeAlD
Sertraline—CYP2C9—cardiovascular system—nicotine dependence	0.000823	0.0585	CbGeAlD
Sertraline—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.000814	0.0038	CbGpPWpGaD
Sertraline—MAOA—midbrain—nicotine dependence	0.000812	0.0576	CbGeAlD
Sertraline—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000807	0.00377	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000791	0.00369	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000761	0.00356	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—CHRNA4—nicotine dependence	0.000757	0.00353	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000751	0.00351	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0007	0.00327	CbGpPWpGaD
Sertraline—SLC6A3—brain—nicotine dependence	0.000686	0.0487	CbGeAlD
Sertraline—SLC6A4—brain—nicotine dependence	0.000629	0.0447	CbGeAlD
Sertraline—SIGMAR1—brain—nicotine dependence	0.000625	0.0444	CbGeAlD
Sertraline—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000623	0.00291	CbGpPWpGaD
Sertraline—MAOB—brain—nicotine dependence	0.000598	0.0425	CbGeAlD
Sertraline—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000587	0.00274	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000579	0.00271	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP2A7—nicotine dependence	0.000562	0.00263	CbGpPWpGaD
Sertraline—SLC6A2—brain—nicotine dependence	0.000554	0.0393	CbGeAlD
Sertraline—MAOA—brain—nicotine dependence	0.00051	0.0362	CbGeAlD
Sertraline—ABCB1—cardiovascular system—nicotine dependence	0.000444	0.0316	CbGeAlD
Sertraline—CYP2B6—brain—nicotine dependence	0.000408	0.029	CbGeAlD
Sertraline—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000353	0.00165	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000348	0.00163	CbGpPWpGaD
Sertraline—ABCB1—midbrain—nicotine dependence	0.000347	0.0246	CbGeAlD
Sertraline—CYP2D6—brain—nicotine dependence	0.000303	0.0215	CbGeAlD
Sertraline—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000221	0.00103	CbGpPWpGaD
Sertraline—ABCB1—brain—nicotine dependence	0.000218	0.0155	CbGeAlD
Sertraline—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000167	0.00078	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000163	0.000762	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000154	0.000718	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000152	0.000712	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.00013	0.000608	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.0001	0.000469	CbGpPWpGaD
